We are live on ! Find out more
CC

Corton Capital Portfolio holdings

AUM $40.7M
1-Year Est. Return 52.32%
This Fund
S&P 500
This Quarter Est. Return
-8.73%
1 Year Est. Return
+52.32%
3 Year Est. Return
+225.1%
5 Year Est. Return
10 Year Est. Return
AUM
$231M
AUM Growth
+$5.66M
Cap. Flow
+$50.5M
Cap. Flow %
21.86%
Top 10 Hldgs %
29.12%
Holding
515
New
301
Increased
21
Reduced
100
Closed
92

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$2.2M
2
ABNB icon
Airbnb
ABNB
+$2.01M
3
TSLA icon
Tesla
TSLA
+$1.84M
4
PSX icon
Phillips 66
PSX
+$1.48M
5
TMO icon
Thermo Fisher Scientific
TMO
+$1.28M

Top Sells

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$1.96M
2
APA icon
APA Corp
APA
+$1.56M
3
SBUX icon
Starbucks
SBUX
+$1.4M
4
COP icon
ConocoPhillips
COP
+$1.36M
5
PFE icon
Pfizer
PFE
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 38.45%
2 Healthcare 13.99%
3 Consumer Discretionary 12.36%
4 Energy 8.37%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
401
Cue Biopharma
CUE
$113M
$68K 0.03%
+464
New +$98.4K
DSP icon
402
Viant Technology
DSP
$236M
$68K 0.03%
+10,378
New +$79.2K
GEO icon
403
The GEO Group
GEO
$4.13B
$68K 0.03%
10,269
-44,042
-81% -$288K
NUVB icon
404
Nuvation Bio
NUVB
$2.2B
$67K 0.03%
+12,760
New +$71.7K
VOR icon
405
Vor Biopharma
VOR
$1.15B
$65K 0.03%
+540
New +$91.9K
NXTC icon
406
NextCure
NXTC
$16.8M
$62K 0.03%
+1,055
New +$66K
VRM icon
407
Vroom Inc
VRM
$39M
$60K 0.03%
+283
New +$134K
CHS
408
DELISTED
Chicos FAS, Inc.
CHS
$60K 0.03%
+12,555
New +$58.8K
CTMX icon
409
CytomX Therapeutics
CTMX
$675M
$57K 0.02%
+21,209
New +$81.4K
AGEN
410
Agenus
AGEN
$312M
$56K 0.02%
+1,155
New +$62.4K
ORIC icon
411
Oric Pharmaceuticals
ORIC
$1.15B
$56K 0.02%
10,501
-6,411
-38% -$57.7K
CNDT icon
412
Conduent
CNDT
$244M
$53K 0.02%
10,338
-44,975
-81% -$221K
GRTS
413
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$53K 0.02%
12,852
-8,449
-40% -$44.8K
STKL
414
DELISTED
SunOpta
STKL
$52K 0.02%
+10,399
New +$54.8K
SURF
415
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$52K 0.02%
+17,586
New +$61.6K
INZY
416
DELISTED
Inozyme Pharma
INZY
$46K 0.02%
+11,350
New +$66.8K
VLDR
417
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$43K 0.02%
+16,603
New +$56.8K
CGEN icon
418
Compugen
CGEN
$222M
$41K 0.02%
+12,783
New +$43.2K
VKTX icon
419
Viking Therapeutics
VKTX
$3.7B
$40K 0.02%
+13,269
New +$47.6K
BYSI icon
420
BeyondSpring
BYSI
$47.3M
$39K 0.02%
+17,583
New +$51K
DTIL icon
421
Precision BioSciences
DTIL
$180M
$39K 0.02%
+420
New +$57.1K
DNTH icon
422
Dianthus Therapeutics
DNTH
$5.84B
$35K 0.02%
+759
New +$41.5K
RBBN icon
423
Ribbon Communications
RBBN
$377M
$32K 0.01%
+10,474
New +$42.9K
ACCO icon
424
Acco Brands
ACCO
$389M
-24,450
Closed -$202K
AHCO icon
425
AdaptHealth
AHCO
$1.47B
-12,124
Closed -$297K

Similar funds

Corton Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Corton Capital held 515 positions worth $231M, up 2.5% from $225M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Corton Capital deployed $50.5M of net new capital in Q1 2022, opening 301 new positions and adding to 21 existing holdings. Its largest new stake was Snowflake: 8,499 shares worth $1.95M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 51% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Occidental Petroleum, an estimated $1.96M trimmed.

  • Corton Capital's largest Q1 2022 buy was Snowflake: 8,499 shares worth $1.95M.
  • Corton Capital added most to EQT Corp in Q1 2022, an estimated $418K increase.
  • Corton Capital's biggest Q1 2022 reduction was Occidental Petroleum, cutting an estimated $1.96M.
  • Corton Capital fully exited Starbucks in Q1 2022, selling an estimated $1.4M.
  • Corton Capital's ten largest holdings make up 29% of its $231M portfolio in Q1 2022.
  • Corton Capital opened 301 new positions and closed 92 in Q1 2022.
  • Corton Capital's portfolio value rose 2.5% quarter-over-quarter to $231M.

Based on Corton Capital's 13F filing for Q1 2022, filed 16 May 2022.